Central Line Associated Blood Stream Infections (CLABSI) are infections in the bloodstream developed within 48 hours of the placement of a central line and not related to another infection site.
- Approximately 4000 episodes in Australian intensive care units each year. Mortality rate of 4–20% with estimated cost of $36.26 million
- additional associated costs of a CR-BSI episode in Europe ranged from €4,200 to €13,030, representing annual costs to healthcare systems of €54 million in the United Kingdom and €130 million in France2
- CLABSI is associated with thousands of deaths and billions of dollars each year in the US, making it one of the deadliest and most costly HAIs.3
- It is estimated that treatment for CLABSI can range from 7 days to 6 weeks and cost an average of roughly $46,000 per case.4
- Despite treatment for CLABSI, it is estimated that 25% of people who contract a CLABSI will die.5